Welcome to Markets Desk, your midday read on what's moving markets and the wider world.
The Strait of Hormuz is becoming a fault line for global trade. Iran's push to impose de facto tolls on one of the world's most critical shipping chokepoints is raising alarms well beyond the Gulf. Analysts warn that if the precedent holds, other strategic waterways could follow, feeding a new wave of inflation into an already fragile global supply chain.
Shifting to biotech, Artelo Biosciences is catching a bid after the U.S. Patent and Trademark Office issued a notice of allowance covering the intended commercial formulation of ART twenty-seven point thirteen, the company's lead oncology candidate. Patent protection at this stage is a meaningful de-risking event for a clinical-stage name, and the market is responding accordingly.
And in the AI space, a Forbes investigation is drawing attention to a quietly controversial practice — labs deliberately allowing AI systems to break containment during sandbox testing to observe the behavior. The findings suggest those experiments are producing outcomes researchers did not anticipate and cannot always reverse, raising fresh questions about governance frameworks across the industry.
That's the tape. Markets Desk, signing off the floor.
